Game over.The clock tics closer to bankruptcy. Implosion.
Karyopharm Delays Endometrial Cancer Program Update Amid FDA Discussions | KPTI Stock News
https://www.stocktitan.net/news/KPT...-endometrial-cancer-program-ergq286y7k55.html
Shareholder lawsuit can’t come soon enoughTranslation: The treatment landscape has evolved to the point where selinexor likely wouldn’t be differentiated and provide incremental benefit or could actually be inferior to the existing standard of care.
The fat lady might not be singing yet, but she’s warming up her vocal cords.
Karyopharm Engages with FDA on Cancer Trial Plans - TipRanks.com
https://www.tipranks.com/news/compa...opharm-engages-with-fda-on-cancer-trial-plans
“Karyopharm Therapeutics Inc., a leader in innovative cancer therapies, is actively engaging with the FDA to discuss the implications of the evolving endometrial cancer treatment landscape on its Phase 3 XPORT-EC-042 trial.”
This Strong guy must be REALLY desperate for a job. There’s got to be a backstory there.Hoping the new IR person does more than just kickoff conference calls and read compliance disclosures. That seems to be all we got in the past.
And R was a disaster as well...gee R...you have been touting Endo as our savior and now a major event happens and you got nothing at all...funny how the narrative has slowly evolved BACK to MF over the last few months - 'they' knew something was up.This Strong guy must be REALLY desperate for a job. There’s got to be a backstory there.
Exactly; all this guy does is dangle one carrot after another. When the one rots, he shifts focus to a new forgotten one. MDS was dangled for a minute only to be pulled back. Forget about that folks, we got Endo, 40 months pfs….not/ how about MF as the holy grail of 19 patients. What a digging joke this guy is. Please just step asideAnd R was a disaster as well...gee R...you have been touting Endo as our savior and now a major event happens and you got nothing at all...funny how the narrative has slowly evolved BACK to MF over the last few months - 'they' knew something was up.
One big shell game...we will lose another batch of people soon as uncertainty and ambiguity are killers. People will get through the holiday season and come the new year people will be actively interviewing for anything stable.
His days must be numbered...NASDAQ deadline is 3/16/25...what material event on the horizon is there that would push us up twenty cents? I understand there is a lot they can't tell us, however hope, for those of us you have stayed, is starting the diminish. We have not had any good news in a long time. Maybe the drug is as a bad as most people tell us it is.Exactly; all this guy does is dangle one carrot after another. When the one rots, he shifts focus to a new forgotten one. MDS was dangled for a minute only to be pulled back. Forget about that folks, we got Endo, 40 months pfs….not/ how about MF as the holy grail of 19 patients. What a digging joke this guy is. Please just step aside
CytoDyn 2.0Maybe this management can stop bullshitting everyone with your fake enthusiasm in that ASH video. Do you really want to make a strong statement then put your money where your mouth is and buy the fucking shares on open market. Everything else is just cheap salesman shit. Let’s see your confident you are in the future by bidding the stock. Such a bunch of scam artists. It’s not surprising that you are trying to spin positive due to the recent SEC filing. Your goal isn’t to enroll trials or get to data; rather it’s to steal more money.